Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
DiGeorge Syndrome: early-phase trial registry
2 of 5 indexed DiGeorge Syndrome trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
DiGeorge Syndrome: 5 US clinical trials tracked, 2 recruiting.
DiGeorge Syndrome is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Progenity, running 1 of these trials.
Enrollment posture brief
Registry condition digeorge-syndrome
OPEN 2 | RECR 40% | LATE 0 | EARLY 3 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
DiGeorge Syndrome lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for DiGeorge Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
DiGeorge Syndrome is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates DiGeorge Syndrome research.
Progenity accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most DiGeorge Syndrome trials plan to enrol fewer than 100 people.
Median target enrolment is 25 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
DiGeorge Syndrome splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Albert Einstein College of Medicine
NCT00556530
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
Paul Szabolcs
NCT07284641
Immune Disorder HSCT Protocol
Washington University School of Medicine
NCT01821781
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Progenity
NCT02787486
Thymus Transplantation Dose in DiGeorge #932
Sumitomo Pharma Switzerland
NCT00576836
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on DiGeorge Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on DiGeorge Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this DiGeorge Syndrome page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 DiGeorge Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Progenity sponsors the most DiGeorge Syndrome trials on record, review their full trial history before evaluating a specific study. See Progenity's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This DiGeorge Syndrome condition card totals 5 registered trials; most-linked intervention Blood sampling for Laboratory Developed Test (LDT) analysis; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.